Candidate gene
| role of GFAP and UCHL1 as candidate biomarkers for pediatric traumatic brain injury (TBI) |
Marker
| marker for astrogliosis, and is a potential biomarker for multiple sclerosis (MS) progression and may have a role in clinical trials for assessing the impact of therapies on MS progression |
|
increased serum GFAP, S100B, ENO2 are associated with acute CO poisoning, and these biomarkers can be useful in assessing the clinical status of patients with CO poisoning |
|
autoantibodies against GFAP could serve as a predictive marker for the development of overt autoimmune diabetes |
|
is a promising diagnostic biomarker for intracerebral hemorrhage (ICH) diagnosis in the early pre-hospital phase |
Therapy target
| |